Business

ADOA Program - SRC Approve Progression to Multi-Dose Study

articlePyc Therapeutics LimitedApril 15, 20265/news/adoa-program-src-approve-progression-to-multi-dose-study

About this update from Pyc Therapeutics Limited

Pyc Therapeutics Ltd has released a press release. View Attachment